Publications by authors named "Shogo Minamikawa"

Parapharyngeal abscess (PPA) is a type of deep neck abscess. Due to its nonspecific clinical manifestations, early diagnosis of PPA is often challenging. Additionally, its anatomical location complicates decisions regarding the necessity of surgical intervention.

View Article and Find Full Text PDF

Objective: To compare the number and incidence of Kawasaki disease (KD) patients in years 2 through 4 of the coronavirus disease 2019 pandemic, and determine the impact of 3 years of implementation of infection control measures and their subsequent relaxation on the epidemiology of KD in Japan.

Study Design: We conducted a population-based, cohort study including consecutive KD patients in Kobe City between 2021 and 2023. We compared the incidence of KD cases, in relation to timing of infection control measures, as well as infectious disease cases based on a regional surveillance system.

View Article and Find Full Text PDF
Article Synopsis
  • The clinical features of panniculitis from Pseudomonas aeruginosa are not well understood, especially compared to ecthyma gangrenosum.
  • A pediatric case of P. aeruginosa panniculitis is reported, highlighting systemic involvement without bacteremia.
  • The patient had a history of autoimmune neutropenia, a characteristic shared with ecthyma gangrenosum but not previously documented in P. aeruginosa panniculitis.
View Article and Find Full Text PDF

In this retrospective cohort study, we investigated the impact of tracheostomies on the long-term survival of children with trisomy 13 syndrome at a Japanese tertiary pediatric center. We compared survival and survival to discharge rates between patients who underwent tracheostomies during their NICU stays (T group, n = 8) and those who did not (non-T group, n = 11). A total of 19 patients enrolled.

View Article and Find Full Text PDF
Article Synopsis
  • * At follow-up, 57% of patients achieved complete remission, but only a small percentage maintained stable remission from 6 to 24 months; younger and older age groups showed lower remission rates.
  • * Severe kidney involvement at diagnosis was identified as a key risk factor for poor outcomes, and the type of initial treatment (mycophenolate vs. cyclophosphamide) did not influence remission stability, highlighting the need for better treatment strategies for pediatric patients.
View Article and Find Full Text PDF

A toddler with an unbalanced diet and gastrointestinal bleeding by juvenile polyp developed an aplastic crisis due to the human parvovirus B19 (HPVB19). Although he exhibited microcytic anemia without iron deficiency in the acute phase of HPVB19 infection, he presented with iron deficiency anemia (IDA) in the chronic phase. IDA results in erythroblast hyperplasia and shortened red blood cell lifespan as like congenital hemolytic diseases, which may lead to an aplastic crisis during HPVB19 infection.

View Article and Find Full Text PDF
Article Synopsis
  • Patients with complicated focal IgA nephropathy (focal IgAN) show a better response to combination therapy, including corticosteroids, compared to diffuse IgA nephropathy (diffuse IgAN).
  • In a study of 88 children, 100% of the focal IgAN group achieved proteinuria disappearance within 2 years, significantly faster than the diffuse IgAN group, which had an 83.9% success rate.
  • The study concludes that combination therapy is effective for complicated focal IgAN, with a favorable long-term prognosis and a suggestion to shorten treatment duration to minimize side effects.
View Article and Find Full Text PDF

The effects of medical and surgical interventions on the survival of patients with trisomy 18 have been reported, leading to changes in perinatal management and decision-making. However, few studies have fully reported the recent changes in survival and treatment of trisomy 18. We examined how treatment and survival of patients with trisomy 18 have changed over a decade in a Japanese pediatric tertiary referral center.

View Article and Find Full Text PDF

Background: Although Lowe syndrome and Dent disease-2 are caused by Oculocerebrorenal syndrome of Lowe (OCRL) mutations, their clinical severities differ substantially and their molecular mechanisms remain unclear. Truncating mutations in OCRL exons 1-7 lead to Dent disease-2, whereas those in exons 8-24 lead to Lowe syndrome. Herein we identified the mechanism underlying the action of novel OCRL protein isoforms.

View Article and Find Full Text PDF

Urinary β2 microglobulin (β2-MG) is a low-molecular-weight protein that is filtered by the glomerular basement membrane and absorbed by the proximal tubule epithelial cells. In perinatal management, urinary β2-MG levels are used to assess intrauterine inflammation in newborns, since urinary excretion increases during inflammation. Furthermore, β2-MG levels in fetal blood and urine are also used for predicting fetal renal function because β2-MG is not transferred to the placenta.

View Article and Find Full Text PDF

Background: Fabry disease is an X-linked inherited lysosomal storage disorder caused by mutations in the gene encoding α-galactosidase A. Males are usually severely affected, while females have a wide range of disease severity. This variability has been assumed to be derived from organ-dependent skewed X-chromosome inactivation (XCI) patterns in each female patient.

View Article and Find Full Text PDF

Background: Dent disease is associated with low molecular weight proteinuria and hypercalciuria and caused by pathogenic variants in either of two genes: CLCN5 (Dent disease 1) and OCRL (Dent disease 2). It is generally not accompanied by extrarenal manifestations and it is difficult to distinguish Dent disease 1 from Dent disease 2 without gene testing. We retrospectively compared the characteristics of these two diseases using one of the largest cohorts to date.

View Article and Find Full Text PDF

Background: X-linked Alport syndrome (XLAS) is a progressive, hereditary glomerular nephritis of variable severity caused by pathogenic COL4A5 variants. Currently, genetic testing is widely used for diagnosing XLAS; however, determining the pathogenicity of variants detected by such analyses can be difficult. Intronic variants or synonymous variants may cause inherited diseases by inducing aberrant splicing.

View Article and Find Full Text PDF

Currently, there are no treatments for Alport syndrome, which is the second most commonly inherited kidney disease. Here we report the development of an exon-skipping therapy using an antisense-oligonucleotide (ASO) for severe male X-linked Alport syndrome (XLAS). We targeted truncating variants in exon 21 of the COL4A5 gene and conducted a type IV collagen α3/α4/α5 chain triple helix formation assay, and in vitro and in vivo treatment efficacy evaluation.

View Article and Find Full Text PDF

Background: Pierson syndrome (PS) is a rare autosomal recessive disorder, characterized by congenital nephrotic syndrome and microcoria. Advances in renal replacement therapies have extended the lifespan of patients, whereas the full clinical spectrum of PS in infancy and beyond remains elusive.

Case Presentation: We present the case of a 12-month-old boy with PS, manifesting as the bilateral microcoria and congenital nephrotic syndrome.

View Article and Find Full Text PDF

Pathogenic variants of paired box gene 2 (PAX2) cause autosomal-dominant PAX2-related disorder, which includes renal coloboma syndrome (RCS). Patients with PAX2-related disorder present with renal and ophthalmological pathologies, as well as with other abnormalities, including developmental problems and hearing loss. We sequenced PAX2 in 457 patients with congenital anomalies of the kidney and urinary tract or with renal dysfunction of unknown cause and identified 19 different pathogenic variants in 38 patients from 30 families (6.

View Article and Find Full Text PDF

Null variants in LAMB2 cause Pierson syndrome (PS), a severe congenital nephrotic syndrome with ocular and neurological defects. Patients' kidney specimens show complete negativity for laminin β2 expression on glomerular basement membrane (GBM). In contrast, missense variants outside the laminin N-terminal (LN) domain in LAMB2 lead to milder phenotypes.

View Article and Find Full Text PDF

X-linked Alport syndrome (XLAS) is a congenital renal disease caused by mutations in COL4A5. In XLAS cases suspected of being caused by aberrant splicing, transcript analysis needs to be conducted to determine splicing patterns and assess the pathogenicity. However, such analysis is not always available.

View Article and Find Full Text PDF